Related Experiment Videos
Multimodality Imaging in Individuals With Anomalous Coronary Arteries
Christoph Gräni1, Ronny R Buechel2, Philipp A Kaufmann2
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JACC. Cardiovascular Imaging
|April 8, 2017
Summary
Anomalous coronary arteries (ACA) are congenital heart conditions. This review focuses on noninvasive imaging to better understand ACA risks and guide optimal patient care.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Medical Imaging
Background:
- Anomalous coronary arteries (ACA) are congenital heart defects involving abnormal coronary artery origins or courses.
- While often asymptomatic, certain ACA variants pose risks for symptoms and adverse cardiac events.
- Current knowledge gaps exist regarding ACA prevalence, pathophysiology, sudden cardiac death risk, and optimal management strategies.
Purpose of the Study:
- To review the current challenges and future perspectives in the assessment and management of anomalous coronary arteries.
- To emphasize the critical role of noninvasive multimodality imaging in evaluating patients with ACA.
- To address the lack of established guidelines for ACA diagnosis, sport restriction, and treatment across all age groups.
Main Methods:
- This is a state-of-the-art review.
- Focuses on noninvasive multimodality cardiac imaging techniques.
- Synthesizes current literature on anomalous coronary arteries.
Main Results:
- Anomalous coronary arteries (ACA) are congenital conditions with varied clinical significance.
- Optimal assessment and treatment strategies for ACA subtypes remain largely undefined.
- Noninvasive imaging is crucial for ACA evaluation and guiding treatment decisions.
Conclusions:
- There is a significant need for improved understanding and standardized guidelines for anomalous coronary arteries (ACA).
- Noninvasive multimodality imaging offers a promising approach for assessing ACA and informing clinical management.
- Further research is needed to elucidate ACA pathophysiology, risks, and evidence-based treatment protocols.